Momentum Project Heidelberg - Dealing Actively With a Cancerous Disease
NCT ID: NCT02678832
Last Updated: 2023-02-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2200 participants
OBSERVATIONAL
2015-12-31
2019-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MOTIVACTION - Study
NCT01576107
Exercise in Pediatric Cancer Patient Undergoing Anti-Cancer Treatment
NCT02216604
Exercise for Young Adults With Cancer
NCT05613699
Multi-professional Care Pathway and Network for the Promotion of Needs-oriented, Resident-oriented Exercise Therapy for Oncological Patients
NCT06185777
Comparison of the Physical Activity in Cancer Patients Assessed by Questionnaire and Motion Tracker
NCT05501379
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Additionally, a follow-up-study with a sub-sample of cancer patients (N=180) will be conducted.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cancer patients
breast cancer prostate cancer colorectal cancer
No interventions assigned to this group
Physicians
working in in- and outpatient care
No interventions assigned to this group
Oncology nurses
working in in- and outpatient care
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* HCP are eligible if they meet the following inclusion criteria: Working as an oncological nurse, general practitioner or physician specialized in oncology, radiology, surgery, gynecology, urology, gastroenterology or rehabilitation Signed informed consent
* Patients are eligible if they meet the following inclusion criteria: Patients with a diagnosis of primary tumor or recurrence no longer than 2 years ago who are undergoing chemo- or radiotherapy currently or in the last 2 years Patients undergoing chemo- or radiotherapy currently or no longer than 2 years ago At least 18 years of age Sufficient German language skills Signed informed consent
Exclusion Criteria:
* HCP will be excluded from the trial if they meet the following exclusion criteria: No regular contact with cancer patients
* Patients will be excluded from the trial if they meet the following exclusion criteria: Presence of comorbidities that preclude involvement in exercise programs (e.g. severe pain, advanced heart failure \[≥ NYHA III\]) Mentally retarded Reduced standing ability and no ability to walk
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
German Cancer Research Center
OTHER
University of Heidelberg Medical Center
OTHER
National Center for Tumor Diseases, Heidelberg
OTHER
German Cancer Aid
OTHER
Heidelberg University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nadine Ungar
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Monika Sieverding, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
Heidelberg University
Karen Steindorf, Prof. Dr.
Role: PRINCIPAL_INVESTIGATOR
German Cancer Research Center (DKFZ) & National Center for Tumor Diseases (NCT), Heidelberg
Joachim Wiskemann, Dr.
Role: PRINCIPAL_INVESTIGATOR
University of Heidelberg Medical Center & National Center for Tumor Diseases (NCT), Heidelberg
References
Explore related publications, articles, or registry entries linked to this study.
Haussmann A, Ungar N, Tsiouris A, Schmidt L, Wiskemann J, Steindorf K, Sieverding M. Better not resting: Carving out attitudes and their associations with physical activity in people with cancer. Eur J Cancer Care (Engl). 2022 Sep;31(5):e13622. doi: 10.1111/ecc.13622. Epub 2022 May 22.
Depenbusch J, Wiskemann J, Haussmann A, Tsiouris A, Schmidt L, Ungar N, Sieverding M, Steindorf K. Impact and Determinants of Structural Barriers on Physical Activity in People with Cancer. Int J Behav Med. 2022 Jun;29(3):308-320. doi: 10.1007/s12529-021-10014-0. Epub 2021 Sep 22.
Related Links
Access external resources that provide additional context or updates about the study.
Homepage of the Study
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
110512/111223
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.